Walhan Alshaer

5.5k total citations · 2 hit papers
119 papers, 3.8k citations indexed

About

Walhan Alshaer is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Walhan Alshaer has authored 119 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 34 papers in Biomaterials and 17 papers in Pharmaceutical Science. Recurrent topics in Walhan Alshaer's work include Nanoparticle-Based Drug Delivery (33 papers), RNA Interference and Gene Delivery (25 papers) and Advanced biosensing and bioanalysis techniques (21 papers). Walhan Alshaer is often cited by papers focused on Nanoparticle-Based Drug Delivery (33 papers), RNA Interference and Gene Delivery (25 papers) and Advanced biosensing and bioanalysis techniques (21 papers). Walhan Alshaer collaborates with scholars based in Jordan, United Kingdom and United Arab Emirates. Walhan Alshaer's co-authors include Hamdi Nsairat, Fadwa Odeh, Abeer Al Bawab, Dima Khater, Said I. Ismail, Usamah Sayed, Elias Fattal, Hervé Hillaireau, Abdalla Awidi and Ma’mon M. Hatmal and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Walhan Alshaer

105 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposomes: structure, composition, types, and clinical applications

2022 808 citations Hamdi Nsairat, Fadwa Odeh et al. Heliyon profile →
siRNA: Mechanism of action, challenges, and therapeutic approaches

2021 296 citations Walhan Alshaer, Lobna Gharaibeh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walhan Alshaer Jordan	29	2.0k	941	730	474	340	119	3.8k
Amr S. Abu Lila Egypt	36	2.1k 1.0×	1.5k 1.6×	922 1.3×	701 1.5×	231 0.7×	143	4.3k
Xiangrong Song China	33	2.5k 1.2×	739 0.8×	787 1.1×	290 0.6×	213 0.6×	147	4.5k
Nagavendra Kommineni India	26	1.7k 0.9×	1.4k 1.5×	1.0k 1.4×	936 2.0×	199 0.6×	53	4.1k
Maria Manuela Gaspar Portugal	35	1.3k 0.7×	774 0.8×	742 1.0×	467 1.0×	162 0.5×	131	3.6k
Xinli Liu China	35	2.3k 1.1×	528 0.6×	949 1.3×	361 0.8×	385 1.1×	169	4.3k
Saman Sargazi Iran	34	1.2k 0.6×	684 0.7×	960 1.3×	249 0.5×	289 0.8×	155	3.2k
Meenakshi Malhotra United States	32	1.4k 0.7×	665 0.7×	586 0.8×	267 0.6×	428 1.3×	107	3.2k
Lifang Yin China	38	1.6k 0.8×	1.6k 1.7×	1.1k 1.4×	1.2k 2.5×	318 0.9×	120	4.6k
Vivek Gupta United States	38	1.6k 0.8×	1.3k 1.4×	1.2k 1.7×	1.1k 2.2×	133 0.4×	109	4.9k
Spyridon Mourtas Greece	25	1.2k 0.6×	837 0.9×	505 0.7×	610 1.3×	280 0.8×	58	2.8k

Countries citing papers authored by Walhan Alshaer

Since Specialization

Citations

This map shows the geographic impact of Walhan Alshaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walhan Alshaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walhan Alshaer more than expected).

Fields of papers citing papers by Walhan Alshaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walhan Alshaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walhan Alshaer. The network helps show where Walhan Alshaer may publish in the future.

Co-authorship network of co-authors of Walhan Alshaer

This figure shows the co-authorship network connecting the top 25 collaborators of Walhan Alshaer. A scholar is included among the top collaborators of Walhan Alshaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walhan Alshaer. Walhan Alshaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Samydai, Ali, et al.. (2025). Codelivery of Raloxifene and Rutin as PEGylated Nanoliposomes: Formulation, Characterization, and Prophylactic Activity Against Breast Cancer. Advanced Pharmaceutical Bulletin. 15(2). 371–389.

Alshaer, Walhan, et al.. (2025). Effect of cucurbit[7]uril on DPPC-containing liposomes: Interactions with the lipid bilayer. Science Progress. 108(2). 352305183–352305183.

Alshaer, Walhan, et al.. (2024). Advancements and Challenges in Aptamer-Based Therapeutics and Diagnostics Across Diverse Medical Domains: A Comprehensive Review. Jordan Journal of Pharmaceutical Sciences. 17(2). 344–361.

Al-Hatamleh, Mohammad A. I., Walhan Alshaer, Ma’mon M. Hatmal, et al.. (2024). Synthesis, characterization, and wound healing activity of alginate-based polymeric nanoparticles loaded with stingless bee honey. Biocatalysis and Agricultural Biotechnology. 60. 103329–103329. 3 indexed citations

Jaber, Nisrein, et al.. (2024). Dual stimuli-responsive polymeric nanoparticles combining soluplus and chitosan for enhanced breast cancer targeting. RSC Advances. 14(5). 3070–3084. 22 indexed citations

Aleidi, Shereen M., et al.. (2024). Research Trend in The Inhibition of Transient Receptor Potential Vanilloid 1 (TRPV1): Bibliometric Analysis and Visualization. Journal of Applied Pharmaceutical Science. 1 indexed citations

Dmour, Isra, et al.. (2024). Preparation of novel shell-ionotropically crosslinked micelles based on hexadecylamine and tripolyphosphate for cancer drug delivery. Pharmaceutical Development and Technology. 29(4). 322–338. 1 indexed citations

Nsairat, Hamdi, et al.. (2023). Impact of nanotechnology on the oral delivery of phyto-bioactive compounds. Food Chemistry. 424. 136438–136438. 31 indexed citations

Al‐Samydai, Ali, et al.. (2023). Preparation, Characterization, and Anticancer Activity of PEGylated Nano Liposomal Loaded with Rutin against Human Carcinoma Cells (HT‐29). Chemistry & Biodiversity. 20(11). e202301167–e202301167. 17 indexed citations

10.

Alshaer, Walhan, et al.. (2023). Cosmeceutical formulations of pro-vitamin E phosphate: In-vitro release testing and dermal penetration into excised human skin. International Journal of Pharmaceutics. 636. 122781–122781. 4 indexed citations

11.

Abuarqoub, Duaa, Nouf N. Mahmoud, Walhan Alshaer, et al.. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines. 11(9). 2490–2490. 2 indexed citations

12.

Alshaer, Walhan, et al.. (2023). Curcumin-loaded γ -cyclodextrin-grafted hyaluronic acid nanoassimblies: In vitro investigation of anti-proliferative, wound healing, and anti-inflammatory potential. Journal of Drug Delivery Science and Technology. 87. 104886–104886. 10 indexed citations

13.

Alshaer, Walhan, et al.. (2023). Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning. RSC Advances. 13(7). 4623–4640. 7 indexed citations

14.

Aljabali, Alaa A. A., et al.. (2022). Molecular and cellular effects of gold nanoparticles treatment in experimental diabetic myopathy. Heliyon. 8(9). e10358–e10358. 13 indexed citations

15.

Abuarqoub, Duaa, et al.. (2022). The Immunomodulatory and Regenerative Effect of Biodentine™ on Human THP‐1 Cells and Dental Pulp Stem Cells: In Vitro Study. BioMed Research International. 2022(1). 2656784–2656784. 11 indexed citations

16.

Hatmal, Ma’mon M., Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.. (2022). Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. Biomedicines. 10(6). 1219–1219. 43 indexed citations

17.

Al‐Trad, Bahaa, Salehhuddin Hamdan, Alaa A. A. Aljabali, et al.. (2021). Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin‐induced type 1 diabetes in rats. IET Nanobiotechnology. 15(5). 473–483. 25 indexed citations

18.

Aljabali, Alaa A. A., Mazhar Salim Al Zoubi, Khalid Al‐Batayneh, et al.. (2019). Gold-coated plant virus as computed tomography imaging contrast agent. Beilstein Journal of Nanotechnology. 10. 1983–1993. 21 indexed citations

19.

Alshaer, Walhan, Dana A. Alqudah, Duaa Abuarqoub, et al.. (2019). Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin. International Journal of Molecular Sciences. 20(15). 3696–3696. 29 indexed citations

20.

Alshaer, Walhan, Hervé Hillaireau, Juliette Vergnaud, et al.. (2017). Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model. Journal of Controlled Release. 271. 98–106. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact